Both ANKRD11 (4.8-fold, p = 0.0087) and ARID1B (6.4-fold change, p < 0.001) mutation associated with higher TMB compared to non-mutated HIV + DLBCL samples. This evidence concerns the gene ANKRD11 and diffuse large B-cell lymphoma.